ETF Analysis: The Schwab U.S. Large-Cap Value ETF (SCHV) has an implied analyst target price of $32.80 per unit, indicating a potential upside of 14.09% from its recent trading price of $28.75.
Notable Holdings: Key underlying holdings with significant upside potential include AMRIZE LTD (AMRZ), Estee Lauder (EL), and CRH plc, with expected price increases of 15.43%, 14.52%, and 14.15% respectively.
Analyst Target Justification: The article raises questions about whether analysts' target prices are justified or overly optimistic, suggesting that high targets may lead to downgrades if they do not align with current market conditions.
Investor Research: Investors are encouraged to conduct further research to assess the validity of analyst targets in light of recent developments in the companies and their industries.
Wall Street analysts forecast EL stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for EL is 106.76 USD with a low forecast of 70.00 USD and a high forecast of 130.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
18 Analyst Rating
Wall Street analysts forecast EL stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for EL is 106.76 USD with a low forecast of 70.00 USD and a high forecast of 130.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
8 Buy
9 Hold
1 Sell
Moderate Buy
Current: 119.490
Low
70.00
Averages
106.76
High
130.00
Current: 119.490
Low
70.00
Averages
106.76
High
130.00
TD Cowen
Hold
maintain
$115 -> $130
2026-01-21
New
Reason
TD Cowen
Price Target
$115 -> $130
AI Analysis
2026-01-21
New
maintain
Hold
Reason
TD Cowen raised the firm's price target on Estee Lauder to $130 from $115 and keeps a Hold rating on the shares. The firm adjusted targets in the beauty space as part of a Q4 preview. TD sees the most upside potential at Estee Lauder on improving China trends and sustained U.S. momentum. Beauty trends appear solid, which should drive revenue upside for all companies, the analyst tells investors in a research note.
JPMorgan
NULL -> Overweight
maintain
$116 -> $131
2026-01-16
Reason
JPMorgan
Price Target
$116 -> $131
2026-01-16
maintain
NULL -> Overweight
Reason
JPMorgan raised the firm's price target on Estee Lauder to $131 from $116 and keeps an Overweight rating on the shares. The firm adjusted ratings and targets in the beverage, household and personal care products group as part of its Q4 earnings preview. JPMorgan believes the sector setup into earnings remains mixed, with the "most plain vanilla companies" and with those with the most exposure to the U.S. consumer likely to post "lackluster" sales. The stocks exposed to beauty and companies that focus on "differentiated and innovative premium products" should continue to outperform, the analyst tells investors in a research note.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for EL
Unlock Now
Barclays
Equal Weight
maintain
$91 -> $100
2026-01-16
Reason
Barclays
Price Target
$91 -> $100
2026-01-16
maintain
Equal Weight
Reason
Barclays raised the firm's price target on Estee Lauder to $100 from $91 and keeps an Equal Weight rating on the shares. The firm adjusted targets in the consumer staples group as part of a Q4 earnings preview. Barclays attributes the recent "enthusiasm" in the stock to "a flight to safety" and remains concerned about company- and sector-level fundamentals. Potential oil and currency headwinds could materialize in 2026, the analyst tells investors in a research note.
RBC Capital
Outperform -> NULL
downgrade
2026-01-08
Reason
RBC Capital
Price Target
2026-01-08
downgrade
Outperform -> NULL
Reason
RBC Capital lowered the firm's price target on EssilorLuxottica to EUR 320 from EUR 340 and keeps an Outperform rating on the shares.
About EL
The Estee Lauder Companies Inc. is a manufacturer, marketer and seller of skin care, makeup, fragrance and hair care products. Its product categories include skin care, makeup, fragrance, hair care and others. Its products are sold in approximately 150 countries and territories under a number of brand names, including Estee Lauder, Aramis, Clinique, Lab Series, Origins, M.A.C, Bobbi Brown Cosmetics, La Mer, Aveda, Jo Malone London, Bumble and bumble, Darphin Paris, TOM FORD, Smashbox, AERIN Beauty, Le Labo, Editions de Parfums Frederic Malle, GLAMGLOW, Kilian Paris, Too Faced, Dr.Jart+, and the DECIEM family of brands, including The Ordinary and NIOD. It is a licensee for fragrances, cosmetics and/or related products for AERIN, BALMAIN, and Dr. Andrew Weil. Its skin care products include moisturizers, serums, cleansers, toners, exfoliators, facial masks, body care, sun care products and others. Its makeup products include lipsticks, lip glosses, mascaras, foundations and others.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
